📢 Gate Square #MBG Posting Challenge# is Live— Post for MBG Rewards!
Want a share of 1,000 MBG? Get involved now—show your insights and real participation to become an MBG promoter!
💰 20 top posts will each win 50 MBG!
How to Participate:
1️⃣ Research the MBG project
Share your in-depth views on MBG’s fundamentals, community governance, development goals, and tokenomics, etc.
2️⃣ Join and share your real experience
Take part in MBG activities (CandyDrop, Launchpool, or spot trading), and post your screenshots, earnings, or step-by-step tutorials. Content can include profits, beginner-friendl
The identification of the executive director of Linghang Medical Biotechnology is exposed: Two founders of Conflux hold concurrent positions.
According to Gate News bot, the latest public information shows that Long Fan and Wu Ming, the two founders of Conflux, also serve as executive directors of the Hong Kong-listed company Leading Pharmaceutical Biotechnology.
Navi Pharmaceutical Biotechnology currently has a total market value of approximately HKD 371 million (equivalent to USD 47.26 million). Meanwhile, the total market value of Conflux (CFX) token has reached USD 393 million, ranking 138th in the cryptocurrency market capitalization leaderboard.
Earlier reports indicated that Pioneer Pharma Biotechnology (00399) announced that the company will sign a memorandum of understanding with Northwestern Foundation (the seller) and Conflux on June 30, 2025, with the intention of acquiring all the shares of the target company. This potential acquisition aims to assist the company in entering the digital innovation field, which will not only diversify the group’s business but is also expected to bring new profit growth points for the group.